| Literature DB >> 19700427 |
J P Osborne1, F J K O'Callaghan.
Abstract
The current regulations for conducting non-commercial clinical trials in Europe are many and complex. These are explored from the perspective of a UK based non-commercial international clinical trial. The reasons for the difficulties encountered are discussed and suggestions made as to how best to overcome them. Improvements are suggested for our law makers and competent authorities. It is argued that the current regulatory environment could be considered unethical as it inhibits and delays research.Mesh:
Year: 2009 PMID: 19700427 DOI: 10.1136/adc.2008.148494
Source DB: PubMed Journal: Arch Dis Child ISSN: 0003-9888 Impact factor: 3.791